Remove HIPAA Remove Immunization Remove Pharmaceutical Companies
article thumbnail

Navigating Executive Orders and DOJ Memos That Threaten Criminal Prosecution

The FDA Law Blog

Second, absent some kind of contractual relationship between a provider and a manufacturer, a provider is generally immune from misbranding if the provider is not also selling a regulated product.